or Try an Advanced Search...

    Kidney Disease Stocks List

    Symbol Grade Name % Change
    CALT B Calliditas Therapeutics AB 1.24
    SNY B Sanofi 0.66
    LGND B Ligand Pharmaceuticals Incorporated -2.46
    TVTX C Travere Therapeutics, Inc. -1.85
    RMTI C Rockwell Medical, Inc. 4.62
    DMAC C DiaMedica Therapeutics Inc. 3.21
    AZN C Astrazeneca PLC -0.25
    TRIB D Trinity Biotech plc 5.42
    XBIO D Xenetic Biosciences, Inc. -8.69
    ICU D SeaStar Medical Holding Corporation 2.71
    View As Page of Charts
    Related Industries: Biotechnology Data Storage Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
    Related Stock Lists: Biopharmaceutical Chronic Kidney Disease Dialysis Medicine Acid Biotechnology End Stage Renal Disease Life Sciences Pharmacy Phosphates Renal Disease Anemia Antibodies Cancer Clinical Medicine Clopidogrel Glucose Health Sciences Hypertension Inflammation

    Related ETFs - A few ETFs which own one or more of the above listed Kidney Disease stocks.

    Symbol Grade Name Weight
    PPH B Market Vectors Pharmaceutical ETF 9.38
    MEDX B Horizon Kinetics Medical ETF 5.73
    IBBQ B Invesco Nasdaq Biotechnology ETF 5.47
    FLUD C Franklin Liberty Ultra Short Bond ETF 4.07
    VIRS B Pacer BioThreat Strategy ETF 3.87
    View all Kidney Disease ETFs...
    Compare ETFs
    Compare FLUD to VIRS Compare MEDX to FLUD Compare PPH to FLUD

        Kidney Disease Stocks Recent News

        Date Stock Title
        Jul 3 SNY Bain, Cinven Weighing Joint Bid for $20 Billion Sanofi Unit
        Jul 3 SNY Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
        Jul 3 SNY Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
        Jul 3 SNY Sanofi, Regeneron win EU label expansion for Dupixent in COPD
        Jul 3 SNY EMA approves Sanofi’s Dupixent for COPD treatment in adults
        Jul 3 SNY Update: Market Chatter: Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits
        Jul 3 SNY Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
        Jul 2 AZN AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use
        Jul 2 SNY Market Chatter: Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits
        Jul 2 AZN EMA fast-tracks review of AstraZeneca’s sipavibart to stop Covid
        Jul 1 AZN AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment
        Jul 1 SNY Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
        Jul 1 SNY Bird Flu Shot Hopes Dim as Tracing Woes Undercut Covid Lessons
        Jul 1 LGND Lifecore Biomedical Announces Cooperation Agreement with 22NW
        Jul 1 SNY Jim Cramer Says You Should Not Buy Novavax Inc (NASDAQ:NVAX)
        Jul 1 AZN AstraZeneca COVID prevention antibody gets EU fast-track review
        Jul 1 SNY Sanofi reports findings from Phase II relapsing MS treatment trial
        Jul 1 SNY Sanofi eyes German insulin investment of up to $1.6 billion, source says
        Jul 1 AZN Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
        Jun 29 SNY Where Will Novavax Be in 1 Year?
        Related Industries: Biotechnology Data Storage Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
        Related Stock Lists: Biopharmaceutical Chronic Kidney Disease Dialysis Medicine Acid Biotechnology End Stage Renal Disease Life Sciences Pharmacy Phosphates Renal Disease Anemia Antibodies Cancer Clinical Medicine Clopidogrel Glucose Health Sciences Hypertension Inflammation
        Kidney Disease

        Kidney disease is a condition in which the kidneys are damaged and unable to filter waste and toxins from the blood. This can lead to a buildup of waste and toxins in the body, which can cause a variety of symptoms, including fatigue, nausea, loss of appetite, and swelling in the hands and feet. In severe cases, kidney disease can lead to kidney failure, which requires dialysis or a kidney transplant.

        Browse All Tags